Stuart J. M. Collinson

Stuart J.
M.
Collinson was the founder of Tioga Pharmaceuticals, Inc., founded in 2005, where the title held was Executive Chairman & Chief Executive Officer.
Current jobs include Venture Partner at Genesys Capital Partners, Inc. and Partner at Forward Ventures Services LLC since 2010.
Former jobs include Chairman, President & Chief Executive Officer at Aurora Biosciences Corp.
from 1999 to 2001; Chairman & Chief Executive Officer at Oxstem Ltd.; Chief Executive Officer at Andaris Ltd.; Co-Chairman-Hospital & Critical Care Therapy at Glaxo Wellcome Plc from 1994 to 1998; Chairman at GeneOhm Sciences, Inc.; Chairman at Conforma Therapeutics Corp.; Executive Chairman at Arcturus Therapeutics, Inc.; Chairman at Affinium Pharmaceuticals Ltd. from 2013 to 2014; Executive Chairman at Arcturus Therapeutics Ltd. from 2015 to 2018; Independent Director at Vertex Pharmaceuticals, Inc. from 2002 to 2011; Director at Asteres, Inc.; Director at NovaCardia, Inc.; Director at Cabrellis Pharmaceuticals Corp.; Independent Director at Soleno Therapeutics, Inc. from 2017 to 2020; Director at Proprius Pharmaceuticals, Inc.; Non-Executive Director at Silence Therapeutics Plc in 2016; Non-Executive Director at Oxagen Ltd. from 2002 to 2012; Director at Essentialis, Inc.; Director at Sequel Pharmaceuticals, Inc.; and Principal at Baxter International, Inc. Education includes a doctorate from the University of Oxford and an MBA from Harvard Business School.